The Burrill Report


The Burrill Report (May 12, 2014): Payers, Pricing, and Their Trust Issues with Pharma (.MP3,5.78 Mb)

Much can be gained by payers and drugmakers working together to address common challenges in the changing world of healthcare, but a new report from EY finds one problem is that payers don’t trust pharmaceutical companies. The new Progressions report also suggests payers will continue to focus on cost containment and prefer predictable expenses rather than turning to outcome-based approaches to drug pricing. We spoke to Patrick Flochel, EY’s global pharmaceutical leader, about the report, what payers are doing to contain drug costs, and what pharmaceutical companies need to do to better adapt to the changing landscape.

May 07, 2014
http://www.burrillreport.com/article-payers_pricing_and_their_trust_issues_with_pharma_.html